share_log

Tilray Will Quintuple Its Medical Marijuana Production In Germany With New Cultivation License

Tilray Will Quintuple Its Medical Marijuana Production In Germany With New Cultivation License

Tilray將在德國增加其醫療大麻生產,擁有新的種植許可證,產量將增加五倍。
Benzinga ·  07/22 13:05

Tilray Brands, Inc. (NASDAQ:TLRY) (TSX:TLRY) announced on Monday that its Germany cannabis cultivation facility, Aphria RX GmbH, has obtained the first new cannabis cultivation license issued under MedCanG, Germany's new Cannabis Act.

Tilray品牌公司(納斯達克股票代碼:TLRY)(TSX:TLRY)週一宣佈,其德國大麻種植設施Aphria RX GmbH已獲得德國新大麻法規MedCanG頒發的首個新大麻種植許可。

Why It Matters

這爲以下原因非常重要

The new cannabis cultivation license allows Aphria RX to cultivate and manufacture a broad commercial range of medical cannabis, providing patients with better access to high-quality medical cannabis produced in Germany.

新的大麻種植許可證允許Aphria RX種植和製造廣泛的商業醫用大麻,爲患者提供更好的在德國生產的高質量醫用大麻的獲取方式。

Denise Faltischek, the company's chief strategy officer and head of international, explained that the license allows Tilray to expand the range of treatment options available to patients. "We appreciate the trust that the German Government has placed in Tilray, and we are proud of our team for their groundbreaking work in medical cannabis cultivation and patient care," Faltischek said.

該公司首席策略官兼國際主管丹尼斯·法爾蒂謝克解釋說,許可證讓Tilray擴大了患者可用的治療選擇範圍。她說:“我們感謝德國政府對Tilray的信任,併爲我們的團隊在醫用大麻種植和患者護理方面的開創性工作感到自豪。”

Read Also: Another Cannabis Pioneer Expands In Germany Via Acquisition As Experts Say 'There's No Stepping Back' From Legalization Wave

閱讀也可以看到:另一家大麻先驅公司通過收購在德國擴大,而專家表示‘無法從合法化潮流中後退'

Aphria RX was awarded the most comprehensive license for the cultivation of medical cannabis in Germany from the German Federal Institute for Drugs and Medical Devices in May 2019. It was awarded a total of five lots (1,000 kgs) and was the only licensed producer in Germany with permission to grow all three strains of medical cannabis approved by the BfArM.

Aphria RX於2019年5月從德國藥品和醫療器械聯邦局獲得了德國醫用大麻種植最全面的許可證。它獲得了總共五批(1000千克)的批次,是唯一一個獲得批准種植BfArm批准的三個醫用大麻品種的德國許可製造商。

Tilray finalized its first harvest of medical cannabis grown in Germany via its German subsidiary Aphria RX in mid-2021. The medical cannabis was distributed to pharmacies in Germany on behalf of the German Cannabis Agency under the country's pharmaceutical and narcotic legal requirements.

Tilray通過其德國子公司Aphria RX在2021年中期完成了在德國種植的醫用大麻的第一次收成。這些醫用大麻是根據德國的藥品和麻醉法規由德國大麻局代表德國的藥品和麻醉合法要求分發到德國藥房的。

What's Next

接下來怎麼做

With the new cannabis license, Tilray can fully utilize and maximize its growing capacity while also expanding its genetics to 31 approved strains from the previously approved three strains.

有了新的大麻許可,Tilray可以充分利用和最大化其種植能力,同時將其遺傳學擴展到之前批准的三個品種的31個批准品種。

In the meantime, the new German law on recreational cannabis went into effect on April 1, partially legalizing cannabis by allowing adults over 18 to possess up to 25 grams of dried cannabis and grow three marijuana plants at home.

與此同時,德國新的娛樂大麻法律於4月1日生效,通過允許年滿18歲的成年人擁有多達25克乾燥大麻和在家中種植三棵大麻來部分合法化大麻。

Cannabis clubs became legal in Germany on July 1, 2024, ahead of the opening of the first marijuana social club a week later. Lower Saxony Minister of Agriculture Miriam Staudte announced in early July that the permit was awarded by her office to Social Club Ganderkesee.

德國大麻俱樂部在2024年7月1日合法化,在一個星期後,第一個大麻社交俱樂部開業。下薩克森州農業部長米里亞姆·施陶特在7月初宣佈,社交俱樂部甘德克塞俱樂部得到了她辦公室授予的許可證。

  • Aurora & Tilray Better Positioned Than Other Cannabis Operators For Germany's Imminent Market Launch, Here's Why
  • Aurora和Tilray比其他大麻運營商更有優勢,可以在德國即將到來的市場上發揮作用,這是爲什麼

To learn more about cannabis innovation, com, join us at the 19th Benzinga Cannabis Capital Conference, coming to Chicago this Oct. 8-9. Get your tickets now before prices surge by following this link.

了解更多有關大麻創新的信息,請訪問com,在即將到來的芝加哥第19屆Benzinga大麻資本會議上與我們一起參加。在點擊以下鏈接之前,立即購買門票,以免價格上漲。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論